Archive for April 2024
Foraco International reports Q1 2024
Foraco International SA has announced its first quarter 2024 results. Tim Bremner, CEO of Foraco, reflected on the quarter, stating, “Q1 2024 stands out as the second-best quarter of the last decade even through the activity level was slightly below that of Q1 2023 when most contracts were remobilized particularly early. Unfavorable exchange rates also…
Read MoreCannara Biotech Reports Q2 2024 Financial Results
Cannara Biotech Inc. has announced its fiscal second quarter 2024 financial and operating results for the three and six-month periods ended February 29, 2024. Highlights include: Net revenue, increased to $19.7 million in Q2 2024 from $13.0 million in Q2 2023, a 51.0% increase. Gross profit, before fair value adjustments, increased to $7.1 million in…
Read MoreBlackline Safety Announces CFO Departure
Blackline Safety Corp. has announced the resignation of CFO, Shane Grennan, effective June 30, 2024. After more than eight years as Chief Financial Officer, Mr. Grennan is leaving Blackline to pursue new career opportunities. Blackline Safety Corp., a client of our Bristol Investor Relations company in Toronto, is a global leader in connected safety technology.…
Read MoreCEMATRIX Announces Record Fourth Quarter & Full Year 2023 Financial Results
CEMATRIX Corporation has announced the release of its consolidated financial results for the quarter and year ending December 31, 2023. The company is delighted with another remarkable quarter culminating in a record year that produced the best financial results in the history of Cematrix. The fourth quarter 2023 revenue was $19.6 million, a 136% increase…
Read MoreLucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
Lucid Diagnostics Inc. has announced that Lucid’s President & Chief Operating Officer Shaun O’Neil will participate in a fireside chat at the 23rd Annual Needham Virtual Healthcare Conference on Thursday, April 11, 2024, at 11:00 a.m. E.T. Lucid Diagnostics Inc., a client of our Bristol Investor Relations company in Toronto, is a commercial-stage, cancer prevention…
Read More